Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kiora Pharmaceuticals Inc. sell Amped

Start price
€2.72
28.07.21 / 0%
Target price
-
28.07.22
Performance (%)
-75.26%
Price
€0.69
20.01.22
Summary
This prediction is currently active. The SELL prediction by Amped for Kiora Pharmaceuticals Inc. is performing very well with a performance of -75.26%. This prediction currently runs until 28.07.22. The prediction end date can be changed by Amped at any time. This prediction was marked as speculative and is excluded from Amped's performance statistics.
Performance without dividends (%)
Name 1w 1m
Kiora Pharmaceuticals Inc. - -
iShares Core DAX® -2.946% -0.274%
iShares Nasdaq 100 -6.914% -10.171%
iShares Nikkei 225® -1.959% -4.210%
iShares S&P 500 -5.128% -5.921%

According to Amped what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Known brand
Cons
High valuation
Sustainability is little important
high free float
Significant cyclical dependencies
Below average Management
Revenue decline/stagnation expected

Comments by Amped for this prediction

In the thread Kiora Pharmaceuticals Inc. diskutieren

Sell Eyegate Pharmaceuticals Inc.